Slideshow: 2023 Vaccine Approvals
Drug Topics
DECEMBER 24, 2023
Vaccine approvals included two immunizations for RSV and a new pentavalent meningococcal shot.
2023 Immunization Vaccines 
New Vaccines Enable Pharmacies to Become Immunization Destinations
Pharmacy Times
SEPTEMBER 25, 2023
For community pharmacists, cooler temperatures, school buses on the roads and Friday night football are not just signs of a changing season – they are indicators that patients will soon be seeking vaccinations for the 2023-2024 respiratory illness season.
Vaccines 
148
148 Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
CDC’s ACIP Votes in Favor of Universal Recommendation for 2023-2024 Monovalent COVID-19 Vaccines
Pharmacy Times
SEPTEMBER 13, 2023
The CDC emphasized the need for protein-based vaccine options in endorsing a vote by the Advisory Committee on Immunization Practices for the universal recommendation of the 2023-2024 monovalent, XBB containing COVID-19 vaccines.
Vaccines 139
139 
Expanding Pneumococcal Vaccinations to Healthy Adults Aged 50 to 64 Years Offers Significant Health, Economic Benefits
Pharmacy Times
JUNE 20, 2025
Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)
Vaccines 73
73 
CDC advisory panel opts for a go-slow approach on expanding usage of RSV vaccines
STAT
JUNE 26, 2024
Makers of RSV vaccines for older adults saw their plans to try to expand usage hit a significant hurdle on Wednesday, when an expert committee that advises the Centers for Disease Control and Prevention on vaccines recommended changes that will likely see fewer older adults qualify for insurance coverage for these products.
Vaccines 136
136 
Bracing for rough respiratory virus season, European officials urge vaccination
STAT
OCTOBER 2, 2023
and Europe are ramping up their campaigns urging eligible people to get another vaccine round against Covid and flu, promoting the immunizations as people’s best way to protect themselves and reduce pressure on health systems during what is expected to be another tough winter. LONDON — Health officials in the U.K.
Vaccines 131
131 
Everything you need to know about the RSV vaccine
The Checkup by Singlecare
SEPTEMBER 22, 2023
This year, there are new vaccines to help at-risk populations ward off severe sickness, including that caused by RSV. Here’s what you need to know about the new FDA-approved RSV vaccine. But young children, older adults, and individuals with weakened immune systems are at high risk of severe, potentially life-threatening RSV illness.
Vaccines 105
105 
Alzheimer’s vaccine granted Fast Track designation
European Pharmaceutical Review
JUNE 27, 2023
AC Immune SA has received Fast Track designation from the US Food and Drug Administration (FDA) for its anti-amyloid beta (Abeta) active immunotherapy vaccine candidate for Alzheimer’s disease. The anti-Abeta therapy “specifically targets the most toxic forms of Abeta” according to Dr Andrea Pfeifer, CEO of AC Immune SA.
Vaccines 105
105 
Next-gen Moderna COVID-19 vaccine shows promise
European Pharmaceutical Review
MARCH 26, 2024
Moderna’s next-generation COVID-19 vaccine mRNA-1283 demonstrated a higher immune response against SARS-CoV-2, interim results from the company’s Phase III trial show. These findings were based on data comparing the treatment to mRNA-1273.222 (Spikevax ® ), Moderna’s licensed vaccine for the condition.
Vaccines 110
110 
EMA panel probes heart inflammation with Pfizer/BioNTech COVID vaccine
pharmaphorum
MAY 10, 2021
A review of side effects reported with coronavirus vaccines by the EMA’s safety committee has uncovered cases of inflammation of the heart in people receiving the Pfizer/BioNTech Comirnaty shot. . It is also asking for similar data from Moderna, which manufacture a COVID-19 vaccine that like Comirnaty is based on mRNA.
Vaccines 122
122 
Latest WHO Covid-19 vaccine guidance may decrease future demand
Pharmaceutical Technology
APRIL 3, 2023
The World Health Organisation (WHO) has revised its recommendations regarding the use of Covid-19 vaccines following a meeting of the agency’s Strategic Advisory Group of Experts on Immunisation (SAGE). The panel emphasised that the extra booster dose recommendation only pertains to one shot and is not for continued annual booster vaccines.
Vaccines 111
111 
Joint Committee on Vaccination and Immunisation provides advice on next round of Covid boosters
Hospital Pharmacy Europe
JANUARY 25, 2023
The Joint Committee on Vaccination and Immunisation (JCVI) has advised offering Covid booster vaccinations in spring and autumn 2023 for patients deemed to be at high risk. The post Joint Committee on Vaccination and Immunisation provides advice on next round of Covid boosters appeared first on Hospital Pharmacy Europe.
Vaccines 98
98 
Implications of RFK Jr.’s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry
PharmTech
JUNE 10, 2025
s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry June 10, 2025 By Christopher Cole News Article The dismissal of all 17 members of the Advisory Committee on Immunization Practices has far-reaching impacts for the industry and beyond. ACIP plays a foundational role in shaping immunization policy in the US.
Vaccines 85
85 
Oragenics secures CQDM funding for Covid-19 vaccine antigen development
Pharmaceutical Technology
JUNE 6, 2023
Oragenics has secured funding from the Canadian bioresearch consortium CQDM to develop a variant-agnostic protein antigen for use in its Covid-19 intranasal vaccine. In March 2023, Oragenics and Inspirevax entered an exclusive global licence deal to develop the former’s lead intranasal Covid-19 vaccine candidate, NT-CoV2-1.
Vaccines 92
92 
Personalising peptide vaccines for treating glioblastoma: expert pharmacist commentary
Hospital Pharmacy Europe
OCTOBER 2, 2024
Pharmacist Dr João Gonçalves PhD considers the real-world evidence of a recent study demonstrating the feasibility and efficacy of a personalised peptide vaccine for glioblastoma – one of the most malignant primary brain tumours in adults. The median overall survival (OS) for the entire cohort was 31.9
Vaccines 52
52 
New Data Showing that Transgene and NEC’s Individualized Cancer Vaccine TG4050 Induces Strong and Specific Immune Responses against Tumors Presented at AACR 2023
Pharmafile
APRIL 18, 2023
CET/4:00 p.m. read more
Immunization 40
40 
First chikungunya vaccine approved
European Pharmaceutical Review
NOVEMBER 10, 2023
The US Food and Drug Administration (FDA) has approved Valneva SE’s IXCHIQ ® , the first chikungunya vaccine to be authorised in the world. The single-dose, live-attenuated vaccine is indicated for preventing chikungunya virus disease in individuals over 18 years old who are at increased risk of contracting the virus.
Vaccines 52
52 
Vaxcyte trains its sight on a lucrative market with pneumococcal vaccine
Pharmaceutical Technology
OCTOBER 28, 2022
On 24 October, American vaccine developer Vaxcyte shared positive topline data from a Phase I/II study of its multivalent conjugate pneumococcal vaccine VAX-24 , bringing the 24-valent pneumococcal jab one step closer to market. What’s more, VAX-24 achieved a higher immune response to 16 of the 20 serotypes it shares with Prevnar 20.
Vaccines 64
64 
Using mRNA to fight cancer: a promising vaccine strategy
Hospital Pharmacy Europe
NOVEMBER 25, 2024
The Covid-19 pandemic boosted advancing technology to create vaccines incorporating messenger RNA. Pharmacist Professor Alain Astier discusses how these vaccines have further potential to be rapidly tailored to target oncogenic profiles and provide significant benefits in personalising cancer treatment. Preventive or therapeutic?
Vaccines 52
52 
Recombinant shingles vaccine could protect against dementia onset, study suggests
Hospital Pharmacy Europe
JULY 26, 2024
The shingles vaccine that has been used in the NHS since last year is associated with a reduced risk of dementia, researchers have reported. A study of more than 200,000 adults before and after the US switched from Zostavax to the Shingrix vaccine found at least a 17% reduction in dementia diagnoses.
Vaccines 52
52 
FDA grants GSK first-ever approval for RSV vaccine
Pharmaceutical Technology
MAY 4, 2023
After a winter marked by a rise in hospitalisations due to the RSV, the FDA has granted its first approval for an Respiratory Syncytial Virus (RSV) vaccine to GSK’s Arexvy for adults ages 60 years and above. This vaccine specifically prevents RSV-related lower respiratory tract disease (LRTD).
Vaccines 64
64 
Mazen Animal Health Receives Patent from the USPTO for its Oral Porcine Epidemic Diarrhea Virus (PEDV) Vaccine
PharmaShots
FEBRUARY 20, 2023
Shots: The USPTO issued the company a patent for its transformative technology to produce orally delivered animal vaccines by the number Patent US-11566255-B2, "Expression of PEDV Sequences in Plants and Plant Produced Vaccine for Same" on the 31st of Jan 2023 The patent covers foundational technology for the company’s first vaccine (..)
Vaccines 40
40 
Next Generation RNA Therapeutics and Vaccines – A Marvel of The Lifesciences Industry
Roots Analysis
OCTOBER 30, 2023
The next generation RNA therapeutics and RNA vaccines pipeline currently features the presence of more than 20 circular RNA therapeutics and vaccines, being developed across initial stages of drug development (discovery and preclinical).
Vaccines 40
40 
Conference Coverage Recap: American Pharmacists Association Annual Meeting and Exposition 2025
Drug Topics
JUNE 23, 2025
McKesson ideaShare: Wrapping Up The Week June 25th 2023 Podcast Drug Topics wraps up a great week in Las Vegas at McKesson ideaShare. McKesson ideaShare: Wrapping Up The Week June 25th 2023 Podcast Drug Topics wraps up a great week in Las Vegas at McKesson ideaShare.
STAT+: Dreams of cancer vaccines are becoming more real. Here are 9 scientists making it happen
STAT
OCTOBER 29, 2024
Vaccines are the original immunotherapy, in the view of Ryan Sullivan, a cancer immunotherapy researcher and oncologist at Mass General Cancer Center. But many other modes of immunotherapy for cancer were approved first — checkpoint blockade drugs like Keytruda and engineered immune cell therapies like Yescarta.
Vaccines 145
145 
Pharmacists Provide Harm Reduction Services to Patients With Substance Use Disorder
Drug Topics
JUNE 10, 2025
She hesitated, and I took her into our immunization room. She admitted she was using them for injection drug use, and I gave her 5 syringes we were using for COVID-19 vaccine injections that were provided by the government. In 2023, they distributed 360,000 syringes and needles through their syringe service program.
Pharmacists Help Patients Manage Chronic Pain
Drug Topics
JUNE 8, 2025
adults, 2023. Related Content Measles Outbreak Reaches Over 800 Confirmed Cases in the US Ashley Gallagher June 7th 2025 Article Building trust with patients through fact-based information could help boost vaccination rates to the desirable coverage. Sign up today for our free Drug Topics newsletter. REFERENCES 1. Lucas JW, Sohi I.
Pneumococcal Burden Remains Despite Immunization Expansion
Drug Topics
JUNE 9, 2025
Investigators found that incorporating either the pneumococcal conjugate vaccine (PCV) 20 or PCV 15 and the 23-valent pneumococcal polysaccharide vaccine (PPSV23) had an incremental budget impact of $6.5 1 The Advisory Committee on Immunization Practices voted to lower the pneumococcal recommendation to 50 years in October 2024.
Immunization 471
471 
The Path to Cervical Cancer Eradication: Overcoming Barriers to HPV Vaccination
Pharmacy Times
JUNE 12, 2025
Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)
Vaccines 65
65 
Wildfires Have Significant Impacts on Respiratory Health
Drug Topics
JUNE 9, 2025
9 In response to the fires in Los Angeles County in January 2025, a 10-year study, called the Los Angeles Fire Human Exposure and Long-Term Health Study, was launched to assess the long-term effects of wildfire smoke exposure, including respiratory, cardiovascular, neurological, reproductive, and immune system impacts. June 7, 2023.
Compounding 247
247 
Are COVID vaccines still free?
The Checkup by Singlecare
MARCH 25, 2025
During the COVID-19 pandemic, broad immunization was key, so the Centers for Disease Control and Prevention (CDC) provided funding for free vaccines. Yet in 2023, federal funding ceased. How much does the COVID vaccine cost without insurance? How much does the COVID vaccine cost without insurance?
Vaccines 52
52 
Pneumococcal Hemolytic Uremic Syndrome Increased Among Children Over Last 15 Years
Drug Topics
JUNE 18, 2025
Following a switch in Sweden’s National Immunization Program (NIP), children in the country reported an increase in pneumococcal hemolytic uremic syndrome (pHUS) from 2009 through 2024. The need for further understanding of pediatric pHUS came when cases quadrupled from 2009 to 2023 among Swedish children under 5. pneumoniae.
Immunization 476
476 
Study Shows High-Dose Vitamin D Boosts Treatment Response in Breast Cancer
Pharmacy Times
JUNE 13, 2025
2 Vitamin D Immunity Vitamin D is a crucial hormone that supports bone health by facilitating the absorption of calcium and phosphorus, which is obtained mainly from sunlight exposure and food. Vitamin D is an accessible and inexpensive option compared to other drugs used to improve the response to chemotherapy.”
Chemotherapy 141
141 
Recommended Immunization Schedules for 2023
Drug Topics
JANUARY 17, 2023
The updates include new recommendations for COVID-19 and pneumococcal vaccines.
Immunization 503
503 
Accelerating AMR vaccine development
European Pharmaceutical Review
NOVEMBER 1, 2023
In July 2022, the World Health Organization (WHO) released its inaugural report on the pipeline of vaccines currently in development to prevent infections caused by antimicrobial resistance (AMR) bacterial pathogens. WHO referred to 61 bacterial vaccine candidates in diverse stages of clinical development. 1 WHO’s analysis was stark.
Vaccines 115
115 
HIV vaccines suffer setbacks but new approaches could turn the tide
Pharmaceutical Technology
FEBRUARY 3, 2023
Only a few weeks into the new year, the prospect of getting a successful advanced HIV vaccine shrank after the discontinuation of yet another late-stage trial. On January 18, Janssen, a Johnson & Johnson (J&J) subsidiary, stated that its vaccine was not effective in preventing HIV infections.
Vaccines 117
117 
Key developments: mRNA vaccines and therapeutics
European Pharmaceutical Review
FEBRUARY 14, 2023
Recently there have been several key advances in the clinical development of messenger RNA (mRNA) vaccines, including vaccines for RSV and a personalised cancer vaccine. Sarah Bundra, Pharmaceutical Analyst at GlobalData also warned about patient safety: “introducing mRNA carries the risk of activating the immune system.”
Vaccines 105
105 
OTC Assessments With Recommendations and Counseling Should Be a Billable Encounter
Pharmacy Times
JUNE 17, 2025
Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)
mRNA vaccine plus KEYTRUDA® improve melanoma survival
European Pharmaceutical Review
DECEMBER 14, 2022
and Merck have announced that a Phase IIb trial ( NCT03897881 ) of a personalised mRNA cancer vaccine (mRNA-4157/V940), in combination with KEYTRUDA ® , Merck’s anti-PD-1 therapy, demonstrated the first randomised evidence that a personalised neoantigen approach may be beneficial in treating melanoma. Moderna, Inc.
Vaccines 116
116 
Pharmacy Star Ratings Changes Coming in 2023
Digital Pharmacist
NOVEMBER 21, 2022
Food and Drug Administration (FDA) announced its approval of the Boostrix vaccine, commonly known as Tdap (combination of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis) for immunization administration during the third trimester of pregnancy to prevent pertussis in infants younger than two months of age.
The imperative of fridge-free vaccines
European Pharmaceutical Review
DECEMBER 19, 2023
Many of today’s vaccines are produced in ready-to-inject liquid formulations that must be kept cold to maintain stability. However, this greatly complicates both the worldwide distribution and stockpiling of vaccines and other drugs. A requisite cold chain has been designed and implemented to be uninterrupted from factory to patient.
Vaccines 111
111 
What to expect with a meningitis vaccine
The Checkup by Singlecare
SEPTEMBER 5, 2023
When you or your child get a vaccine, it’s natural to wonder about possible side effects. The meningitis vaccine is recommended for pre-teens , teens, and specific high-risk individuals with certain health conditions. As with most vaccines, mild side effects are common after the meningitis vaccine.
Vaccines 98
98 
Pioneering malaria vaccine gains regulatory clearance
European Pharmaceutical Review
APRIL 25, 2023
The R21/Matrix-M malaria vaccine, developed by the University of Oxford , has been approved for use in Ghana (13 April 2023) and was authorised for use in Nigeria on 17 April. How does the R21/Matrix-M vaccine work? This technology has been used successfully in Novavax’s COVID-19 vaccine.
Vaccines 111
111 
What Pharmacists Should Know About Medicare Open Enrollment 2023
Digital Pharmacist
OCTOBER 5, 2022
The Medicare Open Enrollment period for 2023 is quickly approaching – this is a critical time for both your patients and your pharmacy. About Medicare Open Enrollment 2023. Part D plans will also cover most vaccines, except for those covered in Part B. Every year, the enrollment period runs from October 15 to December 7.
Let's personalize your content